Response to Comments on “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study”

Detalles Bibliográficos
Autores principales: Akizawa, Tadao, Shimazaki, Ryutaro, Shiramoto, Masanari, Fukagawa, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514161/
https://www.ncbi.nlm.nih.gov/pubmed/30632107
http://dx.doi.org/10.1007/s40261-018-0737-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514161/
https://www.ncbi.nlm.nih.gov/pubmed/30632107
http://dx.doi.org/10.1007/s40261-018-0737-y

Ejemplares similares